TCS Launches New ADD Site Feasibility Platform for Data-driven Clinical Site Selection
Tata Consultancy Services’ Latest Addition to the TCS ADD Suite Digitizes the Site Selection Process and Enables Data-driven Decisions, Driving Superior Clinical Outcomes for Life Sciences Companies
MUMBAI, AUGUST 1, 2019: Tata Consultancy Services (TCS), (BSE: 532540, NSE: TCS) a leading global IT services, consulting and business solutions organization, has launched the ADD Site Feasibility Platform, which provides life sciences companies with a single, integrated platform that digitizes the site selection and activation processes, and facilitates data-driven decision-making while assessing site feasibility for multi-site clinical trials.
In the planning of a clinical study, selection of the right sites for the clinical trials, with the right patient population, investigator profiles, treatment facilities and other parameters, has a huge impact on the study outcomes. Yet, this critical activity was still done manually, resulting in sub-optimal site choices that can result in significant delays and costs. TCS’ Site Feasibility Platform, the latest addition to the Advanced Drug Development (ADD) suite of cloud-based clinical platforms, addresses this critical problem currently faced by life sciences companies, by leveraging the power of digital technologies to drive superior clinical outcomes.
The new platform consolidates data currently residing on multiple systems within the enterprise into a central knowledge repository from which it derives insights that can be used to identify the sites best suited for a given study protocol, with the most appropriate patient population and investigators. It digitizes and automates the entire assessment and selection process, enabling the efficient and coordinated management of hundreds of concurrent clinical trial feasibility studies. Moreover, the platform is fully integrated with the TCS Connected Clinical Trials e-Survey Platform, providing customers with an end-to-end solution for conducting site surveys and analyzing the survey responses.
A leading life sciences company is the first customer to go live with the TCS ADD Site Feasibility Platform. The flexible design enabled rapid implementation within 10 months.
“We are leveraging our deep knowledge of the life sciences industry to continually expand the capabilities of the TCS ADD suite of cloud platforms. The Site Feasibility platform will help our customers digitally transform the most critical study design aspects of their clinical trials and drive superior outcomes,” said Debashis Ghosh, President, Life Sciences and Healthcare, TCS.
About TCS Advanced Drug Development (ADD) Suite:
TCS’ Advanced Drug Development (ADD) suite offers a wide range of Cloud-based clinical services, including Clinical Data Management, Metadata Management, Pharmacovigilance, and Data Analytics and Insights. ADD is powered by a cognitive engine called ‘Decision Fabric’ that enables automation of complex business processes. ADD leverages the best of Cloud architecture and intuitive user experience design in compliance with “Good Clinical Practice” quality guidelines and privacy regulations.
About TCS Life Sciences:
TCS Life Sciences provides top global Life Sciences organizations full service offerings in IT, Consulting, KPO, Infrastructure, and Engineering Services, as well as digital solutions using Mobility, Big Data, Analytics, and Cloud. TCS’ rich industry experience, domain expertise and global footprint allows for a seamless partnership with its Life Sciences customers to help them advance clinical trial efficiencies, accelerate drug discovery, accentuate manufacturing productivity, and amplify sales and marketing effectiveness. In addition, TCS has a dedicated Life Sciences Innovation Lab, which ensures that its customers have the tools and innovative solutions they need to solve complex business challenges.
About Tata Consultancy Services Ltd. (TCS)
Tata Consultancy Services is an IT services, consulting and business solutions organization that has been partnering with many of the world’s largest businesses in their transformation journeys for the last fifty years. TCS offers a consulting-led, cognitive powered, integrated portfolio of business, technology and engineering services and solutions. This is delivered through its unique Location Independent Agile delivery model, recognized as a benchmark of excellence in software development.
A part of the Tata group, India's largest multinational business group, TCS has over 436,000 of the world’s best-trained consultants in 46 countries. The company generated consolidated revenues of US $20.9 billion in the fiscal year ended March 31, 2019, and is listed on the BSE (formerly Bombay Stock Exchange) and the NSE (National Stock Exchange) in India. TCS' proactive stance on climate change and award winning work with communities across the world have earned it a place in leading sustainability indices such as the Dow Jones Sustainability Index (DJSI), MSCI Global Sustainability Index and the FTSE4Good Emerging Index. For more information, visit us at www.tcs.com.
To stay up-to-date on TCS global news, follow @TCS_News.
TCS Media Contacts
Phone: +65 9138 4370
Australia and New Zealand
Phone: +61 422 989 682
Phone: +31 615 903387
Phone: +49 172 6615789
Phone: +46 723 989 188
Phone: +91 22 6778 9960
Phone: +81 80 2115 0989
Phone: +569 6170 9013
Phone: +44 20 3155 2421
USA / Canada
Phone: +1 646 313 4594